Efficacy and Safety of Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Patients with Diabetic Retinopathy

Efficacy and Safety of Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Patients with Diabetic Retinopathy

Background/Aims: The treatment options for diabetic retinopathy (DR) are limited. Mesenchymal stem cells (MSCs) are a promising treatment option for diabetes and its complications. In this pilot clinical trial, we evaluated the safety and efficacy of intravenous autologous bone marrow MSCs (ABMSC) f...

Full description

Bibliographic Details
Main Authors: Xianliang Gu, Xi Yu, Chen Zhao, Ping Duan, Tongtao Zhao, Yong Liu, Shiying Li, Zhi Yang, Yunyan Li, Cheng Qian, Zhengqin Yin, Yi Wang
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2018-08-01
Series:Cellular Physiology and Biochemistry
Subjects:
Diabetic retinopathy
Mesenchymal stem cell
Stem cell transplantation
Best corrected visual acuity
Macular thickness
Online Access:https://www.karger.com/Article/FullText/492838

Internet

https://www.karger.com/Article/FullText/492838

Similar Items